RALOXIFENE TEVA 60 mg, comprimé pelliculé — plaquette(s) thermoformée(s) aluminium PVC PVDC de 84 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400949335107
  • CIP7 4933510
  • CIS 67050747
  • Registration number EU/1/10/627

What the source publishes

Holder
TEVA (PAYS-BAS)
Active ingredients
CHLORHYDRATE DE RALOXIFÈNE, RALOXIFÈNE BASE
Form
comprimé pelliculé
Package
plaquette(s) thermoformée(s) aluminium PVC PVDC de 84 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
liste I
Marketing status
Déclaration de commercialisation
Authorised on
2010-04-29
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400949335107
{
  "cis": "67050747",
  "cip7": "4933510",
  "form": "comprimé pelliculé",
  "name": "RALOXIFENE TEVA 60 mg, comprimé pelliculé — plaquette(s) thermoformée(s) aluminium PVC PVDC de 84 comprimé(s)",
  "cip13": "3400949335107",
  "holder": "TEVA (PAYS-BAS)",
  "routes": [
    "orale"
  ],
  "holders": [
    "TEVA (PAYS-BAS)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "33.63",
  "authorisedOn": "2010-04-29",
  "compositions": [
    {
      "name": "CHLORHYDRATE DE RALOXIFÈNE",
      "nature": "SA",
      "strength": "60 mg",
      "linkageNumber": "1",
      "substanceCode": "79270",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "RALOXIFÈNE BASE",
      "nature": "FT",
      "strength": "56 mg",
      "linkageNumber": "1",
      "substanceCode": "93678",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "2.76",
  "medicinePrice": "30.87",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "RALOXIFENE TEVA 60 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) thermoformée(s) aluminium PVC PVDC de 84 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65%"
  ],
  "marketingDeclaredOn": "2011-03-15",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "CHLORHYDRATE DE RALOXIFÈNE",
    "RALOXIFÈNE BASE"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": "Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Prévention et traitement de l'ostéoporose postménopausique du rachis, pour réduire le risque de fractures vertébrales, chez les femmes âgées de moins de 70 ans, sans facteur de risque veineux et avec apport de calcium<br> ; JOURNAL OFFICIEL ; 17/05/01",
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/10/627",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400949335107"